A shadow market for unlicensed slimming medications is propelled by TikTok fitness influencers and sellers on communication apps, based on new investigations.
Investigational Drug Gaining Traction Via Social Media
The experimental drug, which remains in clinical trials, is being promoted by online personalities for its supposed weight-reducing effects. Followers are urged to contact these accounts privately for supplier links, while also obtaining discount codes.
Active Commerce on Messaging Platforms
Additionally, a robust trade exists on messaging services, where groups with thousands of participants share “before and after” images, injection guides and claims of next-day UK delivery. Vendors market the drug there before directing buyers to other platforms for purchases.
Understanding The Experimental Drug
This medication is an experimental injectable developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist patients lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.
Medical Professionals Express Worries
However, doctors and pharmacists have warned that the distribution of what remains an unlicensed medication in the UK is worrisome and could result in users administering substances of unknown origin.
Several professionals stated the popularity for retatrutide could be connected to the rising cost of licensed weight loss treatments such as Mounjaro.
Regulatory Status and Implementation
Marketing the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Several influencers attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still breach pharmaceutical, advertising, and customer laws, risking fines, legal action or imprisonment.
Platform Reaction and Material Elimination
According to the social media company, the platform has removed problematic material and prohibited related hashtags and query recommendations. The organization said it was committed to maintaining the platform safe and investing in strengthening compliance measures.
Online Trading Activities
Investigations also discovered groups with up to 9,000 members selling retatrutide using Telegram's built-in discovery tool, which operates like a public directory. Entering “retatrutide” immediately displays channels with thousands of users, filled with photos of weight loss, positive testimonials and detailed guides for preparing or administering at home.
Within minutes of entering one group, a seller posted contact information, where the majority of purchases take place. The seller sent an instruction manual and promised shipping within two days. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one asked about body mass, health issues or past usage.
Product Details and Pricing
Within these communities, messages show black plastic packages with Royal Mail labels, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at residence with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20mg. When asked how much time a injector should be used, sellers give conflicting answers varying between a several days to “depends on your body”.
Service Moderation and Security Actions
A representative for Telegram said it actively monitored harmful material on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are injecting substances they can’t verify. Although the science behind retatrutide is sound, these online versions may not contain what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the increase in interest to current cost increases for approved slimming drugs such as Mounjaro. “With prices rising, patients are using online platforms. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the conditions they were produced in was clean,” she said.
Her staff has previously seen patients harmed by personal administration from unverified sources. “We understand the frustration, but buying from Telegram or WhatsApp is gambling with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”
Manufacturer Position
A representative from Eli Lilly stated the substance was in third stage clinical trials and had not been reviewed or authorized by any government authority globally. “Consequently at this point no one can market [it] for human use,” they explained, adding that any item “falsely representing itself as a company investigational product not yet authorized … may expose users to potentially significant health risks”.
